Myriad Genetics to Present Multiple Studies at the 2019 American Society of Clinical Oncology Annual Meeting

San Francisco, CA (UroToday.com) -- Myriad Genetics, Inc., a leader in personalized medicine, announced that it will present results from multiple studies at the 2019 American Society of Clinical Oncology (ASCO) annual meeting to be held May 31 to June 4, 2019, in Chicago, Ill. Abstracts of the company's presentations will be available at abstracts.asco.org on May 15 at 5:00 p.m. EDT.

"Myriad is committed to advancing personalized medicine and providing oncologists with high-quality genetic information to enhance care for their patients," said Johnathan Lancaster, M.D., Ph.D., chief medical officer, Myriad Genetics.

"At this year’s ASCO, we are excited to present multiple studies that highlight the clinical performance of several of Myriad’s genetic tests.” 
A list of presentation at ASCO 2019 are below. Please visit Myriad Genetics at booth #5087 to learn more about our leading portfolio of personalized medicine products. Follow Myriad on Twitter via @myriadgenetics and keep up to date with ASCO meeting news and updates by using the hashtag #ASCO19.

Featured Research at 2019 ASCO

Complete ASCO 2019 Conference Highlights Coming Soon!
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe